skip to main content
Refinado por: Base de dados/Biblioteca: Gale Academic OneFile remover assunto: Radiotherapy remover PubMed Central remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?
Material Type:
Artigo
Adicionar ao Meu Espaço

Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?

Shakespeare, Thomas P ; Wilcox, Shea W ; Aherne, Noel J

OncoTargets and therapy, 2016-01, Vol.9 (Issue 1), p.1635-1639 [Periódico revisado por pares]

New Zealand: Dove Medical Press Limited

Texto completo disponível

2
Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?
Material Type:
Artigo
Adicionar ao Meu Espaço

Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?

Shakespeare, Thomas P ; Wilcox, Shea W ; Aherne, Noel J

OncoTargets and therapy, 2016-01, Vol.9 (Issue 1), p.2819-2824 [Periódico revisado por pares]

New Zealand: Dove Medical Press Limited

Texto completo disponível

3
Long-term outcomes from dose-escalated image-guided intensity-modulated radiotherapy with androgen deprivation: encouraging results for intermediate- and high-risk prostate cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Long-term outcomes from dose-escalated image-guided intensity-modulated radiotherapy with androgen deprivation: encouraging results for intermediate- and high-risk prostate cancer

Wilcox, Shea W ; Aherne, Noel J ; Benjamin, Linus C ; Wu, Bosco ; de Campos Silva, Thomaz ; McLachlan, Craig S ; McKay, Michael J ; Last, Andrew J ; Shakespeare, Thomas P

OncoTargets and therapy, 2014-01, Vol.7 (default), p.1519-1523 [Periódico revisado por pares]

New Zealand: Dove Medical Press Limited

Texto completo disponível

Buscando em bases de dados remotas. Favor aguardar.